Oncofetal Chondroitin Sulfate: A Putative Therapeutic Target in Adult and Pediatric Solid Tumors

por Khazamipour, Nastaran, Al-Nakouzi, Nader, Oo, Htoo Zarni, Ørum-Madsen, Maj, Steino, Anne, Sorensen, Poul H, Daugaard, Mads
Publicado 2020

Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer

por Oo, Htoo Zarni, Lohinai, Zoltan, Khazamipour, Nastaran, Lo, Joey, Kumar, Gunjan, Pihl, Jessica, Adomat, Hans, Nabavi, Noushin, Behmanesh, Hakhamanesh, Zhai, Beibei, Dagil, Robert, Choudhary, Swati, Gustavsson, Tobias, Clausen, Thomas M., Esko, Jeffrey D., Allen, Jeffrey W., Thompson, Michael A., Tran, Nhan L., Moldvay, Judit, Dome, Balazs, Salanti, Ali, Al-Nakouzi, Nader, Weiss, Glen J., Daugaard, Mads
Publicado 2021

Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer

por Al-Nakouzi, Nader, Wang, Chris Kedong, Oo, Htoo Zarni, Nelepcu, Irina, Lallous, Nada, Spliid, Charlotte B., Khazamipour, Nastaran, Lo, Joey, Truong, Sarah, Collins, Colin, Hui, Desmond, Esfandnia, Shaghayegh, Adomat, Hans, Clausen, Thomas Mandel, Gustavsson, Tobias, Choudhary, Swati, Dagil, Robert, Corey, Eva, Wang, Yuzhuo, Chauchereau, Anne, Fazli, Ladan, Esko, Jeffrey D., Salanti, Ali, Nelson, Peter S., Gleave, Martin E., Daugaard, Mads
Publicado 2022

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1

por Peacock, James W, Takeuchi, Ario, Hayashi, Norihiro, Liu, Liangliang, Tam, Kevin J, Al Nakouzi, Nader, Khazamipour, Nastaran, Tombe, Tabitha, Dejima, Takashi, Lee, Kevin CK, Shiota, Masaki, Thaper, Daksh, Lee, Wilson CW, Hui, Daniel HF, Kuruma, Hidetoshi, Ivanova, Larissa, Yenki, Parvin, Jiao, Ivy ZF, Khosravi, Shahram, Mui, Alice L‐F, Fazli, Ladan, Zoubeidi, Amina, Daugaard, Mads, Gleave, Martin E, Ong, Christopher J
Publicado 2018